Neomycin and Eczema-Like Rashes: What a 70-Study Allergy Review Means for the First-Aid Kit

Doctor’s Notes · Eczema Research · November 2026

When an itchy rash persists around a minor injury, the treatment placed on it belongs in the history alongside the original scrape. Neomycin is an antibiotic used in some topical products and is also a recognized contact allergen. A recent review puts that possibility into a broader research context.

What the pooled numbers represent

A 2025 systematic review included 70 studies of dermatitis patients undergoing patch testing. It estimated neomycin contact allergy at 3.2% in adults and 4.3% in children, with regional variation. North American pooled estimates were higher than European estimates. These are selected testing populations with differences between studies, not a trial showing the probability of allergy after one application or a diagnosis for a particular rash.

Read combination products ingredient by ingredient

A sports bag or family first-aid kit may contain a product identified only as an antibiotic ointment. Photograph the active and inactive ingredients and note each application. A combination formula can contain more than one potential cause of dermatitis. Do not assume that the antibiotic ingredient is responsible simply because it appears in a research review.

Distinguish a contact reaction from infection

A clinician may need to decide whether worsening symptoms reflect infection, contact dermatitis, both or another issue. Spreading redness, increasing pain, fever or an unwell child should not be managed by repeatedly trying different creams. If a medicine was prescribed, contact its prescriber about a suspected reaction and the appropriate next treatment rather than substituting a cosmetic moisturizer.

Use the result to improve the kit, not to improvise treatment

After assessment, ask which exact ingredients must be avoided and what wound-care products are appropriate for your circumstances. Keep that record where another caregiver can find it. For a coach or healthcare professional, separate personal product choices from organizational protocols. The research supports taking medication exposure seriously; it does not make a blog a wound-management instruction sheet.

For related questions, read our guide to a wound product that makes the rash worse and our discussion of eczema or skin infection? warning signs, antibiotics and when to get help. These address connected care decisions rather than establishing the cause of an individual rash.

Where Dr. Arsy #003 fits

Dr. Arsy #003 is not an antibiotic, infection treatment or wound dressing. Its role is cosmetic hydration and moisture-barrier support on appropriate skin according to the package. The neomycin review did not evaluate #003, and a suspected medicine allergy needs its own assessment.

Other products in a first-aid routine may raise questions about benzalkonium chloride irritation or allergy or tape-related colophonium allergy. Those possibilities require different product and testing details.

Sources and further reading

1. Primary research record, PubMed
2. Research report and additional evidence
3. NIH MedlinePlus: Contact Dermatitis

Written by the Dr. Arsy Editorial Team for general education, not independent medical review. Discuss diagnosis and treatment with a qualified clinician. #003 is a cosmetic moisturizer, not an eczema medicine. Image is an AI-generated editorial scene using the actual jar as reference. PubMed indexing does not imply NIH endorsement.